Replies to post #225253 on Avid Bioservices Inc (CDMO)

[CuresForHumanity]

Robert,
Phase 2, all patients had previously treated Stage IIIb or IV non-squamous NSCLC. Phase 3 study states the same,
"SUNRISE: A Phase III, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Previously Treated Stage IIIb/IV Non-Squamous Non Small-Cell Lung Cancer"

Am I missing something?